Prostaglandin signalling in cerebral ischaemia

Katrin Andreasson1

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA. kandreas@stanford.edu

Insights

Cyclooxygenase-2 (COX-2) causes neurotoxicity in neurological diseases. This study investigates the prostaglandin EP3 receptor

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The enzyme cyclooxygenase-2 (COX-2) plays a role in neurological diseases, contributing to neurotoxicity.
  • Prostaglandins, synthesized by COX enzymes, are key mediators in various biological processes, including neurological functions.
  • Understanding downstream prostaglandin signaling is crucial for identifying therapeutic targets in neurological disorders.

Discussion:

  • This research investigates the specific role of the prostaglandin E2 (PGE2) EP3 receptor in the context of cerebral ischemia.
  • The study explores the signaling pathways potentially activated by the EP3 receptor, including Rho kinase activation.
  • Investigating specific prostaglandin receptors helps elucidate their dual roles (neurotoxic or neuroprotective) in neurological conditions.

Key Insights:

  • The inducible cyclooxygenase-2 (COX-2) contributes to neurotoxic effects observed in models of cerebral ischemia and neurodegeneration.
  • While some prostaglandin receptors mediate toxic effects, others exhibit paradoxical protective roles in neurological disease models.
  • The EP3 receptor's function in transient focal ischemia models and its potential Rho kinase signaling are examined.

Outlook:

  • Further research into specific prostaglandin receptor functions can reveal novel therapeutic strategies for neurological diseases.
  • Elucidating the precise signaling mechanisms of receptors like EP3 could lead to targeted interventions for conditions like stroke.
  • This work contributes to a deeper understanding of the complex roles prostaglandins play in the central nervous system.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...